Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Short Bowel Syndrome market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Short Bowel Syndrome market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category GLP-2 Growth Hormone Glutamine Others Segmented by End User/Segment Hospitals Clinics Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Zealand Pharma Takeda Sancilio & Company OxThera Nutrinia Naia Pharmaceuticals Merck GlyPharma Therapeutics Emmaus Life Sciences Ardelyx

List of Figures

Figure Short Bowel Syndrome Picture
Figure Global Short Bowel Syndrome Sales Value (Million USD) and Growth Rate (2016-2027)
Figure Global Short Bowel Syndrome Sales Value CAGR (2020-2027) by Region
Figure Global Short Bowel Syndrome Sales Value Market Share by Company, 2020
Figure Product Picture of GLP-2
Figure Product Picture of Growth Hormone
Figure Product Picture of Glutamine
Figure Product Picture of Others
Figure Global Short Bowel Syndrome Sales Value Market Share by Category, 2020
Figure North America Short Bowel Syndrome Sales Value Market Share by Category, 2020
Figure Europe Short Bowel Syndrome Sales Value Market Share by Category, 2020
Figure Asia Pacific Short Bowel Syndrome Sales Value Market Share by Category, 2020
Figure Central & South America Short Bowel Syndrome Sales Value Market Share by Category, 2020
Figure Middle East & Africa Short Bowel Syndrome Sales Value Market Share by Category, 2020
Figure Short Bowel Syndrome in Hospitals
Figure Global Short Bowel Syndrome Market: Hospitals (2016-2021)
Figure Short Bowel Syndrome in Clinics
Figure Global Short Bowel Syndrome Market: Clinics (2016-2021)
Figure Global Short Bowel Syndrome Sales Value Market Share by End User/Segment, 2020
Figure North America Short Bowel Syndrome Sales Value Market Share by End User/Segment, 2020
Figure Europe Short Bowel Syndrome Sales Value Market Share by End User/Segment, 2020
Figure Asia Pacific Short Bowel Syndrome Sales Value Market Share by End User/Segment, 2020
Figure Central & South America Short Bowel Syndrome Sales Value Market Share by End User/Segment, 2020
Figure Middle East & Africa Short Bowel Syndrome Sales Value Market Share by End User/Segment, 2020
Figure Global Short Bowel Syndrome Sales Value Market Share by Region (2016-2021)
Figure North America Short Bowel Syndrome Sales Value (Million USD) Status (2016-2021)
Figure Europe Short Bowel Syndrome Sales Value (Million USD) Status (2016-2021)
Figure Asia Pacific Short Bowel Syndrome Sales Value (Million USD) Status (2016-2021)
Figure Central & South America Short Bowel Syndrome Sales Value (Million USD) Status (2016-2021)
Figure Middle East & Africa Short Bowel Syndrome Sales Value (Million USD) Status (2016-2021)
Figure North America Short Bowel Syndrome Sales Value Market Share by Country, 2020
Figure United States Short Bowel Syndrome Sales Value (Million USD) Status (2016-2021)
Figure Canada Short Bowel Syndrome Sales Value (Million USD) Status (2016-2021)
Figure Mexico Short Bowel Syndrome Sales Value (Million USD) Status (2016-2021)

Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Short Bowel Syndrome Market Status and Forecast (2016-2027) 1.3.2 Global Short Bowel Syndrome Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Short Bowel Syndrome Supply by Company 2.1 Global Short Bowel Syndrome Sales Value by Company 2.2 Short Bowel Syndrome Sales Area of Main Manufacturers 2.3 Trend of Concentration Rate3 Global and Regional Short Bowel Syndrome Market Status by Category 3.1 Short Bowel Syndrome Category Introduction 3.1.1 GLP-2 3.1.2 Growth Hormone 3.1.3 Glutamine 3.1.4 Others 3.2 Global Short Bowel Syndrome Market by Category 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Short Bowel Syndrome Market Status by End User/Segment 4.1 Short Bowel Syndrome Segment by End User/Segment 4.1.1 Hospitals 4.1.2 Clinics 4.2 Global Short Bowel Syndrome Market by End User/Segment 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Short Bowel Syndrome Market Status by Region 5.1 Global Short Bowel Syndrome Market by Region 5.2 North America Short Bowel Syndrome Market Status 5.3 Europe Short Bowel Syndrome Market Status 5.4 Asia Pacific Short Bowel Syndrome Market Status 5.5 Central & South America Short Bowel Syndrome Market Status 5.6 Middle East & Africa Short Bowel Syndrome Market Status6 North America Short Bowel Syndrome Market Status 6.1 North America Short Bowel Syndrome Market by Country 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Short Bowel Syndrome Market Status 7.1 Europe Short Bowel Syndrome Market by Country 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Short Bowel Syndrome Market Status 8.1 Asia Pacific Short Bowel Syndrome Market by Country 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Short Bowel Syndrome Market Status 9.1 Central & South America Short Bowel Syndrome Market by Country 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Short Bowel Syndrome Market Status 10.1 Middle East & Africa Short Bowel Syndrome Market by Country 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Major Downstream Customers Analysis 11.1 Customer One Analysis 11.2 Customer Two Analysis 11.3 Customer Three Analysis 11.4 Customer Four Analysis12 Global Short Bowel Syndrome Market Forecast by Category and by End User/Segment 12.1 Global Short Bowel Syndrome Sales Value Forecast (2022-2027) 12.2 Global Short Bowel Syndrome Forecast by Category 12.3 Global Short Bowel Syndrome Forecast by End User/Segment13 Global Short Bowel Syndrome Market Forecast by Region/Country 13.1 Global Short Bowel Syndrome Market Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Zealand Pharma 14.1.1 Company Information 14.1.2 Short Bowel Syndrome Product Introduction 14.1.3 Zealand Pharma Short Bowel Syndrome Sales Value, Gross Margin and Global Share (2019-2021) 14.1.4 SWOT Analysis 14.2 Takeda 14.2.1 Company Information 14.2.2 Short Bowel Syndrome Product Introduction 14.2.3 Takeda Short Bowel Syndrome Sales Value, Gross Margin and Global Share (2019-2021) 14.2.4 SWOT Analysis 14.3 Sancilio & Company 14.3.1 Company Information 14.3.2 Short Bowel Syndrome Product Introduction 14.3.3 Sancilio & Company Short Bowel Syndrome Sales Value, Gross Margin and Global Share (2019-2021) 14.3.4 SWOT Analysis 14.4 OxThera 14.4.1 Company Information 14.4.2 Short Bowel Syndrome Product Introduction 14.4.3 OxThera Short Bowel Syndrome Sales Value, Gross Margin and Global Share (2019-2021) 14.4.4 SWOT Analysis 14.5 Nutrinia 14.5.1 Company Information 14.5.2 Short Bowel Syndrome Product Introduction 14.5.3 Nutrinia Short Bowel Syndrome Sales Value, Gross Margin and Global Share (2019-2021) 14.5.4 SWOT Analysis 14.6 Naia Pharmaceuticals 14.6.1 Company Information 14.6.2 Short Bowel Syndrome Product Introduction 14.6.3 Naia Pharmaceuticals Short Bowel Syndrome Sales Value, Gross Margin and Global Share (2019-2021) 14.6.4 SWOT Analysis 14.7 Merck 14.7.1 Company Information 14.7.2 Short Bowel Syndrome Product Introduction 14.7.3 Merck Short Bowel Syndrome Sales Value, Gross Margin and Global Share (2019-2021) 14.7.4 SWOT Analysis 14.8 GlyPharma Therapeutics 14.8.1 Company Information 14.8.2 Short Bowel Syndrome Product Introduction 14.8.3 GlyPharma Therapeutics Short Bowel Syndrome Sales Value, Gross Margin and Global Share (2019-2021) 14.8.4 SWOT Analysis 14.9 Emmaus Life Sciences 14.9.1 Company Information 14.9.2 Short Bowel Syndrome Product Introduction 14.9.3 Emmaus Life Sciences Short Bowel Syndrome Sales Value, Gross Margin and Global Share (2019-2021) 14.9.4 SWOT Analysis 14.10 Ardelyx 14.10.1 Company Information 14.10.2 Short Bowel Syndrome Product Introduction 14.10.3 Ardelyx Short Bowel Syndrome Sales Value, Gross Margin and Global Share (2019-2021) 14.10.4 SWOT Analysis15 Conclusion16 Methodology